Mona Zeus1, Stefan Janssen2, Hans-Jürgen Laws1, Ute Fischer1, Arndt Borkhardt1, Prasad Thomas Oommen3. 1. Department of Pediatric Oncology, Hematology and Clinical Immunology, Divison of Pediatric Rheumatology, University Children's Hospital, Medical Faculty, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany. 2. Algorithmic Bioinformatics, Department of Biology and Chemistry, Justus Liebig University Giessen, Giessen, Germany. 3. Department of Pediatric Oncology, Hematology and Clinical Immunology, Divison of Pediatric Rheumatology, University Children's Hospital, Medical Faculty, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany. Prasad.Oommen@med.uni-duesseldorf.de.
Abstract
OBJECTIVE: To analyze the composition of the oral microbiome in children and adolescents with chronic nonbacterial osteomyelitis (CNO) with respect to age distribution, gender differences, effects of medication, disease activity and the influence of body site. METHODS: The oral microbiome of 20 patients (12 male and 8 female; median age 10.3 years) and 36 controls were examined. Two different sites of the oral cavity were swabbed at two time points. Current medication and disease activity were evaluated and registered at these time points. Samples were subjected to amplicon sequencing of the V4 region of the 16S rRNA gene and Qiime2 was used to calculate alpha and beta diversity for multiple alternative metrics. RESULTS: On the basis of relative abundances of 975 different suboperational taxonomic units in high throughput next generation sequencing, a significant shift in the composition of the oral microbiome (p < 0.02) was observed among patients being treated with different medications. There was a significant difference in bacterial communities between the group aged 3-8 years old and the group aged 9-14 years old. Significant differences were also seen in bacterial colonization on different sites in the oral cavity, but not with respect to gender or disease activity. CONCLUSION: We present first data of a pilot study of the oral microbiome in children and adolescents with CNO, a rare autoinflammatory bone disease. Differences of the oral microbiome of diseased children to normal adult controls revealed a possible role of the oral microbiome as modulatory target or biomarker in CNO.
OBJECTIVE: To analyze the composition of the oral microbiome in children and adolescents with chronic nonbacterial osteomyelitis (CNO) with respect to age distribution, gender differences, effects of medication, disease activity and the influence of body site. METHODS: The oral microbiome of 20 patients (12 male and 8 female; median age 10.3 years) and 36 controls were examined. Two different sites of the oral cavity were swabbed at two time points. Current medication and disease activity were evaluated and registered at these time points. Samples were subjected to amplicon sequencing of the V4 region of the 16S rRNA gene and Qiime2 was used to calculate alpha and beta diversity for multiple alternative metrics. RESULTS: On the basis of relative abundances of 975 different suboperational taxonomic units in high throughput next generation sequencing, a significant shift in the composition of the oral microbiome (p < 0.02) was observed among patients being treated with different medications. There was a significant difference in bacterial communities between the group aged 3-8 years old and the group aged 9-14 years old. Significant differences were also seen in bacterial colonization on different sites in the oral cavity, but not with respect to gender or disease activity. CONCLUSION: We present first data of a pilot study of the oral microbiome in children and adolescents with CNO, a rare autoinflammatory bone disease. Differences of the oral microbiome of diseased children to normal adult controls revealed a possible role of the oral microbiome as modulatory target or biomarker in CNO.
Authors: Evan Bolyen; Jai Ram Rideout; Matthew R Dillon; Nicholas A Bokulich; Christian C Abnet; Gabriel A Al-Ghalith; Harriet Alexander; Eric J Alm; Manimozhiyan Arumugam; Francesco Asnicar; Yang Bai; Jordan E Bisanz; Kyle Bittinger; Asker Brejnrod; Colin J Brislawn; C Titus Brown; Benjamin J Callahan; Andrés Mauricio Caraballo-Rodríguez; John Chase; Emily K Cope; Ricardo Da Silva; Christian Diener; Pieter C Dorrestein; Gavin M Douglas; Daniel M Durall; Claire Duvallet; Christian F Edwardson; Madeleine Ernst; Mehrbod Estaki; Jennifer Fouquier; Julia M Gauglitz; Sean M Gibbons; Deanna L Gibson; Antonio Gonzalez; Kestrel Gorlick; Jiarong Guo; Benjamin Hillmann; Susan Holmes; Hannes Holste; Curtis Huttenhower; Gavin A Huttley; Stefan Janssen; Alan K Jarmusch; Lingjing Jiang; Benjamin D Kaehler; Kyo Bin Kang; Christopher R Keefe; Paul Keim; Scott T Kelley; Dan Knights; Irina Koester; Tomasz Kosciolek; Jorden Kreps; Morgan G I Langille; Joslynn Lee; Ruth Ley; Yong-Xin Liu; Erikka Loftfield; Catherine Lozupone; Massoud Maher; Clarisse Marotz; Bryan D Martin; Daniel McDonald; Lauren J McIver; Alexey V Melnik; Jessica L Metcalf; Sydney C Morgan; Jamie T Morton; Ahmad Turan Naimey; Jose A Navas-Molina; Louis Felix Nothias; Stephanie B Orchanian; Talima Pearson; Samuel L Peoples; Daniel Petras; Mary Lai Preuss; Elmar Pruesse; Lasse Buur Rasmussen; Adam Rivers; Michael S Robeson; Patrick Rosenthal; Nicola Segata; Michael Shaffer; Arron Shiffer; Rashmi Sinha; Se Jin Song; John R Spear; Austin D Swafford; Luke R Thompson; Pedro J Torres; Pauline Trinh; Anupriya Tripathi; Peter J Turnbaugh; Sabah Ul-Hasan; Justin J J van der Hooft; Fernando Vargas; Yoshiki Vázquez-Baeza; Emily Vogtmann; Max von Hippel; William Walters; Yunhu Wan; Mingxun Wang; Jonathan Warren; Kyle C Weber; Charles H D Williamson; Amy D Willis; Zhenjiang Zech Xu; Jesse R Zaneveld; Yilong Zhang; Qiyun Zhu; Rob Knight; J Gregory Caporaso Journal: Nat Biotechnol Date: 2019-08 Impact factor: 54.908
Authors: J Wipff; F Costantino; I Lemelle; C Pajot; A Duquesne; M Lorrot; A Faye; B Bader-Meunier; K Brochard; V Despert; S Jean; M Grall-Lerosey; Y Marot; D Nouar; A Pagnier; P Quartier; C Job-Deslandre Journal: Arthritis Rheumatol Date: 2015-04 Impact factor: 10.995
Authors: Christine Beck; Henner Morbach; Meinrad Beer; Martin Stenzel; Dennis Tappe; Stefan Gattenlöhner; Ulrich Hofmann; Peter Raab; Hermann J Girschick Journal: Arthritis Res Ther Date: 2010 Impact factor: 5.156
Authors: John R Lukens; Prajwal Gurung; Peter Vogel; Gordon R Johnson; Robert A Carter; Daniel J McGoldrick; Srinivasa Rao Bandi; Christopher R Calabrese; Lieselotte Vande Walle; Mohamed Lamkanfi; Thirumala-Devi Kanneganti Journal: Nature Date: 2014-09-28 Impact factor: 49.962
Authors: Daniel McDonald; Embriette Hyde; Justine W Debelius; James T Morton; Antonio Gonzalez; Gail Ackermann; Alexander A Aksenov; Bahar Behsaz; Caitriona Brennan; Yingfeng Chen; Lindsay DeRight Goldasich; Pieter C Dorrestein; Robert R Dunn; Ashkaan K Fahimipour; James Gaffney; Jack A Gilbert; Grant Gogul; Jessica L Green; Philip Hugenholtz; Greg Humphrey; Curtis Huttenhower; Matthew A Jackson; Stefan Janssen; Dilip V Jeste; Lingjing Jiang; Scott T Kelley; Dan Knights; Tomasz Kosciolek; Joshua Ladau; Jeff Leach; Clarisse Marotz; Dmitry Meleshko; Alexey V Melnik; Jessica L Metcalf; Hosein Mohimani; Emmanuel Montassier; Jose Navas-Molina; Tanya T Nguyen; Shyamal Peddada; Pavel Pevzner; Katherine S Pollard; Gholamali Rahnavard; Adam Robbins-Pianka; Naseer Sangwan; Joshua Shorenstein; Larry Smarr; Se Jin Song; Timothy Spector; Austin D Swafford; Varykina G Thackray; Luke R Thompson; Anupriya Tripathi; Yoshiki Vázquez-Baeza; Alison Vrbanac; Paul Wischmeyer; Elaine Wolfe; Qiyun Zhu; Rob Knight Journal: mSystems Date: 2018-05-15 Impact factor: 6.496